TAGLN2 and central nervous system cancer: TAGLN2 mRNA levels were significantly different between IDH1/2 WT grade II (n=21), grade III (n=52) and grade IV (n=133) gliomas from the TCGA database (p< 0.0001) (Figure 1D).